Kazakhstan: An OTC and pharma market full of potential
The young and fast-growing consumer healthcare and pharma market in Kazakhstan is young but promising and full of opportunities for European markets.
Background of the OTC and Pharma market in Kazakhstan
The OTC and pharma market in Kazakhstan is young. After the collapse of the Soviet Union, Kazakhstan lacked any established pharmaceutical companies, infrastructure, or experience. Nevertheless, the 1990s saw the establishment of Kazakhstan’s first Pharma companies, and, over time, more and more foreign companies found their way to the potential market there, which is very much influenced by imports.
At present, the share of domestic manufacturers in the procurement of medicines and medical devices has grown to 30% and continues to grow steadily.
All in all, Kazakhstan is a very promising country with its growth bolstered by the demand for innovative healthcare products such as prescription medications, medical devices, OTC and food supplements, as well as for medical expertise. The consumer healthcare and pharma market of Kazakhstan should reach more than USD 1,32 billion by 2035 ex-factory, according to the Chameleon Pharma Consulting Group forecast.
Chameleon Pharma Consulting Group has developed a systematic partner search process that can identify the most suitable local partner for you in Kazakhstan in only 10-12 weeks. Simply contact us for more details!
Kazakhstan OTC and pharma market in 2035
USD 1,32 Billion
OTC and pharma market size, ex-factory
OTC and pharma market growth
Kazakhstan in numbers
Interested in this market ?
We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.